REFERENCIAS BIBLIOGRAFICAS

1. Fwu CW, Eggers PW, Kimmel PL, et al. Emergency department visits, use
of imaging, and drugs for urolithiasis have increased in the United States.
Kidney Int 2013; 83:479.
2. Singh P, Enders FT, Vaughan LE, et al. Stone Composition Among First-
Time Symptomatic Kidney Stone Formers in the Community. Mayo Clin
Proc 2015; 90:1356.
3. Lieske JC, Rule AD, Krambeck AE, et al. Stone composition as a function of
age and sex. Clin J Am Soc Nephrol 2014; 9:2141.
4. Teichman JM. Clinical practice. Acute renal colic from ureteral calculus. N
Engl J Med 2004; 350:684.
5. Evan AP, Lingeman JE, Coe FL, et al. Randall's plaque of patients with
nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin
Invest 2003; 111:607.
6. Kim SC, Coe FL, Tinmouth WW, et al. Stone formation is proportional to
papillary surface coverage by Randall's plaque. J Urol 2005; 173:117.
7. Evan AP, Coe FL, Rittling SR, et al. Apatite plaque particles in inner medulla
of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney
Int 2005; 68:145.
8. Evan AP, Worcester EM, Coe FL, et al. Mechanisms of human kidney stone
formation. Urolithiasis 2015; 43 Suppl 1:19.
9. Ferraro PM, Curhan GC, Gambaro G, Taylor EN. Total, Dietary, and
Supplemental Vitamin C Intake and Risk of Incident Kidney Stones. Am J
Kidney Dis 2016; 67:400.
10. Hiatt RA, Ettinger B, Caan B, et al. Randomized controlled trial of a low
animal protein, high fiber diet in the prevention of recurrent calcium oxalate
kidney stones. Am J Epidemiol 1996; 144:25.
11. Kocvara R, Plasgura P, Petrík A, et al. A prospective study of nonmedical
prophylaxis after a first kidney stone. BJU Int 1999; 84:393.
12. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the
prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med
2002; 346:77.
13. Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med 1989;
111:1006.
14. Ferraro PM, Curhan GC, D'Addessi A, Gambaro G. Risk of recurrence of
idiopathic calcium kidney stones: analysis of data from the literature. J
Nephrol 2017; 30:227.
15. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of
kidney stones. J Am Soc Nephrol 1997; 8:1568.
16. Lloyd SE, Pearce SH, Fisher SE, et al. A common molecular basis for three
inherited kidney stone diseases. Nature 1996; 379:445.
17. Goodyer P, Saadi I, Ong P, et al. Cystinuria subtype and the risk of
nephrolithiasis. Kidney Int 1998; 54:56.
18. Bollée G, Dollinger C, Boutaud L, et al. Phenotype and genotype
characterization of adenine phosphoribosyltransferase deficiency. J Am Soc
Nephrol 2010; 21:679.
19. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with
modern bariatric surgery. J Urol 2007; 177:565.
20. Nelson WK, Houghton SG, Milliner DS, et al. Enteric hyperoxaluria,
nephrolithiasis, and oxalate nephropathy: potentially serious and
unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat
Dis 2005; 1:481.
21. Duffey BG, Pedro RN, Makhlouf A, et al. Roux-en-Y gastric bypass is
associated with early increased risk factors for development of calcium
oxalate nephrolithiasis. J Am Coll Surg 2008; 206:1145.
22. Kopp JB, Miller KD, Mican JA, et al. Crystalluria and urinary tract
abnormalities associated with indinavir. Ann Intern Med 1997; 127:119.
23. Sasson JP, Dratch PL, Shortsleeve MJ. Renal US findings in sulfadiazine-
induced crystalluria. Radiology 1992; 185:739.
24. Carr MC, Prien EL Jr, Babayan RK. Triamterene nephrolithiasis: renewed
attention is warranted. J Urol 1990; 144:1339.
25. Avci Z, Koktener A, Uras N, et al. Nephrolithiasis associated with ceftriaxone
therapy: a prospective study in 51 children. Arch Dis Child 2004; 89:1069.